Transparency Market Research
Allergic rhinitis, which is commonly known as hay fever, is an allergic response to specific allergens. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen, such as pollen, mold, dust, etc., the body release a chemical known as histamine, which defends the body from the allergen. This chemical causes allergy symptoms or allergic rhinitis. Pollen is the most common allergen in seasonal allergic rhinitis. Common symptoms of allergic rhinitis are sneezing, runny nose, stuffy nose, watery eyes, headaches, hives, excessive fatigue, skin rashes, etc..
Higher prevalence and incidence of allergic rhinitis among people is expected to drive the allergic rhinitis drugs market during the forecast period. According to a report of the World Allergy Organization, in 2015, around 400 million people suffered from allergic rhinitis across the globe. The introduction of new drugs and nasal sprays for allergic rhinitis is expected to drive the allergy rhinitis drugs market. However, the availability of generic drugs and side effects of allergy rhinitis drugs, such as dry mouth, drowsiness, constipation, agitation, urinary retention, etc., are anticipated to hamper the market in the coming years.
Based on drug class, the global allergic rhinitis drugs market can be classified into oral antihistamines, intranasal corticosteroids, immunotherapies, intranasal antihistamines, and other allergic rhinitis drugs. The oral antihistamines segment is projected to account for a significant share of the market in the near future, as oral antihistamines effectively work to treat allergic rhinitis symptoms with their longer duration of action. Moreover, the new generation of oral antihistamines are less likely to cause side effects. In terms of disease, the allergic rhinitis drugs market can be segmented into seasonal allergic rhinitis, perennial allergic rhinitis, and occupational rhinitis. The perennial allergic rhinitis segment is expected to expand during the forecast period because the symptoms of allergic rhinitis are present throughout the year. Based on route of administration, the market can be categorized into oral and nasal. The oral segment is expected to expand in the coming years, as the oral route of administration is convenient and makes the drugs more bioavailable. In terms of distribution channel, the allergic rhinitis drugs market can be categorized into hospital pharmacies, retail pharmacies, and others. The retail pharmacies segment is expected to constitute a considerable share of the market during the forecast period. This is because nowadays many brands of antihistamines are available over the counter, and patients can buy them easily without a doctor’s prescription. Patients prefer to visit retail pharmacies and buy drugs from retail pharmacies for their convenience.
In terms of region, the global allergic rhinitis drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global allergic rhinitis drugs market during the forecast period due to high incidence of allergic rhinitis in countries such as the U.S. and Canada. According to the American College of Allergy, Asthma, & Immunology, every year, 40 to 60 million people are effected by allergic rhinitis in North America. According to the European Academy of Allergy and Clinical Immunology, in 2016, more than 150 million people were effected by chronic allergic diseases in Europe. By 2025, the affected population is expected to more than double. An increase in the affected population in Europe is creating demand for drugs to treat allergic rhinitis. This is anticipated to drive the allergic rhinitis drug market in Europe. Rise in the prevalence of allergic rhinitis and launch of new drugs to treat the condition are estimated to propel the allergic rhinitis drugs market in Asia Pacific.
Major players operating in the global allergic rhinitis drugs market include GlaxoSmithKline, Merck & Co., Sanofi, Johnson & Johnson, Dr. Reddy’s Laboratories, Allergy Therapeutics, Mylan NV, Sun Pharmaceuticals, Pfizer Inc., and Stallergenes Greer.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.